Chih Kang Ke
Director/Board Member bij TAHO PHARMACEUTICALS LTD
Profiel
Chih Kang Ke is an Independent Director at TAHO Pharmaceuticals Ltd.
He previously worked as a Managing Director & Investment Director at Global Strategic Investment Management, Inc., an Independent Director at Easywell Biomedicals, Inc., an Independent Director at MACHVISION, Inc., and a Member-Supervisory Board at PharmaDax Inc.
Actieve functies van Chih Kang Ke
| Bedrijven | Functie | Begin |
|---|---|---|
| TAHO PHARMACEUTICALS LTD | Director/Board Member | - |
Eerdere bekende functies van Chih Kang Ke
| Bedrijven | Functie | Einde |
|---|---|---|
| EASYWELL BIOMEDICALS, INC. | Director/Board Member | - |
| MACHVISION INC. | Director/Board Member | - |
| PHARMADAX INC. | Director/Board Member | - |
| Global Strategic Investment Management, Inc. | Chief Executive Officer | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| EASYWELL BIOMEDICALS, INC. | Health Technology |
| MACHVISION INC. | Producer Manufacturing |
| Bedrijven in privébezit | 3 |
|---|---|
| Global Strategic Investment Management, Inc. | Finance |
PharmaDax Inc.
 PharmaDax Inc. Pharmaceuticals: MajorHealth Technology PharmaDax Inc. engages in the development and marketing of generic dossiers. Its products include Glyburide, Quetiapine Fumarate ER, and Metoprolol Succinate ER tablets. The company was founded by Yi Pin Huang on March 21, 2008 and is headquartered in New Taipei, Taiwan. | Health Technology |
TAHO Pharmaceuticals Ltd.
 TAHO Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Taho Pharmaceuticals Ltd. engages in the research and development of pharmaceutical products. Its Technology Platform products are the Transepithelial Delivery System, Transdermal DDS, Transmucosal SSD, and Bio-Revie. The firm's Research & Development products include medicines for migraine, alzheimer's disease, hyperactivity disorder, and nausea caused by chemotherapy. The company was founded on July 7, 2010 and is headquartered in Taipei, Taiwan. | Health Technology |
